"THE RELATIONSHIP BETWEEN PARKINSON'S DISEASE AND TYPE 2 DIABETES MELLITUS: CLINICAL FEATURES AND PATHOPHYSIOLOGICAL MECHANISMS"
Keywords:
Parkinson's disease, Type 2 diabetes mellitus, Neurological featuresAbstract
Parkinson’s disease (PD) and type 2 diabetes mellitus (T2DM) are two widely prevalent chronic diseases that significantly affect the quality of life of patients. In recent years, the number of studies dedicated to analyzing the interaction between these diseases has been growing. In particular, clinical and neurological features of Parkinson's disease in the context of T2DM are being studied. This review article presents the results of an analysis of modern research on this topic
References
Zoler, M. L. (2021). Type 2 Diabetes Worsens Parkinson's Disease. Medscape. https://www.medscape.com/viewarticle/962501
Sazonova, O. V., Goldobina, Y. V., Degtyar, N. S., & Lasovskaya, T. Y. (2018). Evaluation of the quality of life of patients with type 2 diabetes. Diabetes mellitus, 21(1), 36-43. https://doi.org/10.14341/DM8837
World Health Organization. (2021). Parkinson's Disease. https://www.who.int/ru/news-room/fact-sheets/detail/parkinson-disease
Lukyanchikov, V. S. (2016). Diabetic neuropathy. Russian Medical Journal, 24(7), 440-444. https://www.rmj.ru/articles/obshchie-stati/Diabeticheskaya_nevropatiya/
Cell therapy for Alzheimer's disease, Parkinson's disease, and vascular dementia. (n.d.). MedTour Help.https://medtour.help/ru/disease/kletochnaya-terapiya-bolezni-alczgejmera-sindroma-parkinsona-i-sosudistoj-demenczii
The number of people with diabetes has reached 422 million, according to Reuters. (2016). Russian Medical Journal. https://www.rmj.ru/news/chislo-bolnykh-diabetom-dostiglo-422-mln-chelovek/
Troshneva, A. Y., Levin, O. S., & Ametov, A. S. (2016). The relationship between Parkinson's disease and type 2 diabetes. Ural Medical Journal, 11(140), 102-106. https://umedp.ru/articles/vzaimosvyaz-bolezni-parkinsona-i-sakharnogo-diabeta-2-tipa
Komici K, et al. J Parkinsons Dis. 2021;11(4):1585-1596.https://internist.ru/publications/detail/sakharnyy-diabet-uskoryaet-progressirovanie-bolezni-parkinsona/?sphrase_id=366225
Mitochondrial Dysfunction, Oxidative Stress A.Picca · 2020 · https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466131/
The Role of Oxidative Stress in Parkinson's Disease Vera Dias, Eunsung Junn, and M. Maral Mouradian https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135313/
Parkinson's Disease, Diabetes and Cognitive Impairment Mohammad R Ashraghi, Gennaro Pagano, Sotirios Polychronis, Flavia Niccolini, Marios Politis https://pubmed.ncbi.nlm.nih.gov/27396477/
Novel Treatment Opportunities Against Cognitive Impairment in Parkinson’s Disease with an Emphasis on Diabetes-Related Pathways Holly Green, Panagiota Tsitsi, Ioanna Markaki, Dag Aarsland, and Per Svenningsson https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373401/
Non-motor features of Parkinson disease Schapira etal https://pubmed.ncbi.nlm.nih.gov/28720825/ https://www.researchgate.net/publication/317441933_Non-motor_features_of_Parkinson_disease
Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's diseaseSantiago Perez-Lloret et al. NPJ Parkinsons Dis. 2016https://pubmed.ncbi.nlm.nih.gov/28725692/
Parkinson's disease, insulin resistance and novel agents of neuroprotect on 2013
Iciar Aviles-Olmos, Patricia Limousin, Andrew Lees, Thomas Foltyniehttps://academic.oup.com/brain/article/136/2/374/287025
Petrou M, Davatzikos C, Hsieh M, Albin R, Kotagal V, Müller M, Koeppe RA, Herman WH, Frey KA, Bohnen NI (2016) Diabetes, gray matter loss and cognition in the setting of Parkinson Disease, Acad Radiol 23, 577–581 https://pubmed.ncbi.nlm.nih.gov/26874576/
Shared dysregulated pathways lead to Parkinson's disease and diabetes Jose A Santiago , Judith A Potashkin2013,2016 https://pubmed.ncbi.nlm.nih.gov/23375873/
Clinical features of Parkinson disease when onset of diabetes came first E. Cereda, M. Barichella, E. Cassani, R. Caccialanza, G. Pezzoli https://n.neurology.org/content/78/19/1507
Diabetes mellitus and Parkinson’s disease: dangerous liaisons between insulin and dopamine
Angela De Iuliis,1 Ennio Montinaro,2 Giuseppe Fatati,3 Mario Plebani,1,4 and Carlo Colosimo 2021 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504381/
Mechanism of the neuroprotective effect of GLP-1 in a rat model of Parkinson's with pre-existing diabetes Eman A Elbassuoni et al. Neurochem Int. 2019 Dec. https://pubmed.ncbi.nlm.nih.gov/31654678/
A New Treatment Strategy for Parkinson's Disease through the Gut–Brain AxisThe Glucagon-Like Peptide-1 Receptor Pathway Dong Seok Kim, Ho-Il Choi,Yun Wang,Yu Luo, Barry J. Hoffer, and Nigel H. 2017 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680957/
Exenatide and the treatment of patients with Parkinson's disease Aviales-Olmosetal.2013 https://pubmed.ncbi.nlm.nih.gov/23728174/
Diabetes and the risk of developing Parkinson's disease in Denmark Eva Schernhammer et al. Diabetes Care https://pubmed.ncbi.nlm.nih.gov/21411503/
Diabetes mellitus and Parkinson disease Gennaro Pagano , Sotirios Polychronis , Heather Wilson , Beniamino Giordano , Nicola Ferrara , Flavia Niccolini , Marios Politis https://pubmed.ncbi.nlm.nih.gov/29626177/ 2018
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
